clinical trials

Regeneron CEO cautions Trump’s results are ‘a case of one,’ and coronavirus drug needs more testing
Regeneron CEO cautions Trump’s results are ‘a case of one,’ and coronavirus drug needs more testing
Marketwatch
Regeneron
Donald Trump
antibodies
COVID-19
clinical trials
Flag link:
Key trial test begins for plasma-based COVID-19 therapy from Takeda, CSL
Key trial test begins for plasma-based COVID-19 therapy from Takeda, CSL
BioPharma Dive
clinical trials
plasma
COVID-19
Takeda
CSL
Flag link:
Pfizer's breast cancer drug Ibrance fails late-stage study
Pfizer's breast cancer drug Ibrance fails late-stage study
Reuters
Pfizer
clinical trials
Ibrance
breast cancer
Flag link:
Noxopharm announces first Covid-19 patient treated in Veyonda study
Noxopharm announces first Covid-19 patient treated in Veyonda study
Pharmaceutical Business Review
Noxopharm
Veyonda
COVID-19
clinical trials
Flag link:
Eli Lilly and Gilead’s combination cuts COVID-19 recovery time
Eli Lilly and Gilead’s combination cuts COVID-19 recovery time
Pharmaforum
Eli Lilly
olumiant
baricitinib
Gilead Sciences
Veklury
remdesivir
COVID-19
clinical trials
NIH
Flag link:
COVID-19 vaccine trial recruiters explain widespread distrust, misinformation among potential enrollees
COVID-19 vaccine trial recruiters explain widespread distrust, misinformation among potential enrollees
Beckers Hospital Review
Moderna Therapeutics
COVID-19
clinical trials
clinical trial recruitment
trust
Flag link:
Amgen and Cytokinetics claim heart drug success, but results widely disappoint
Amgen and Cytokinetics claim heart drug success, but results widely disappoint
BioPharma Dive
Amgen
Cytokinetics
Servier
clinical trials
Omecamtiv Mecarbil
cardiovascular disease
Flag link:
Bristol Myers Squibb Announces Phase III Results Exploring the Potential of Opdivo
Bristol Myers Squibb Announces Phase III Results Exploring the Potential of Opdivo
BioSpace
Bristol-Myers Squibb
clinical trials
non-small cell lung cancer
Opdivo
Flag link:
Pfizer and Sangamo Dose First Participant in Phase 3 Study Evaluating Hemophilia A Gene Therapy Treatment SB-525
Pfizer and Sangamo Dose First Participant in Phase 3 Study Evaluating Hemophilia A Gene Therapy Treatment SB-525
Drugs.com
Pfizer
Sangamo Therapeutics
genomics
clinical trials
hemophilia A
giroctocogene fitelparvovec
SB-525
Flag link:
Expect Pfizer/BioNTech and Moderna Coronavirus Vaccine Data Readouts in November-December, U.S. Vaccine Program Head Says
Expect Pfizer/BioNTech and Moderna Coronavirus Vaccine Data Readouts in November-December, U.S. Vaccine Program Head Says
Motley Fool
Operation Warp Speed
Pfizer
BioNTech
Moderna Therapeutics
vaccines
COVID-19
AstraZeneca
clinical trials
Flag link:
As AstraZeneca’s Covid-19 vaccine trial remains on hold in U.S., participants waiting on a second dose are in limbo
As AstraZeneca’s Covid-19 vaccine trial remains on hold in U.S., participants waiting on a second dose are in limbo
Stat
AstraZeneca
vaccines
COVID-19
clinical trials
Flag link:
Corbus Pharma’s Lenabasum Fails Again, This Time in Cystic Fibrosis
Corbus Pharma’s Lenabasum Fails Again, This Time in Cystic Fibrosis
BioSpace
Corbus Pharma
lenabasum
cystic fibrosis
clinical trials
Flag link:
Santhera flunks DMD phase 3, prompting restructuring and withdrawal of approval application
Santhera flunks DMD phase 3, prompting restructuring and withdrawal of approval application
Fierce Biotech
Santhera Pharmaceuticals
clinical trials
Duchenne Muscular Dystrophy
idebenone
Flag link:
GSK, Vir cleared to leap into PhIII, angling for a spot in the Covid-19 antibody race led by Lilly, Regeneron
GSK, Vir cleared to leap into PhIII, angling for a spot in the Covid-19 antibody race led by Lilly, Regeneron
Endpoints
GSK
Vir Biotechnology
COVID-19
clinical trials
Flag link:
Amgen teases 'promising' phase 2 data for closely watched KRAS prospect
Amgen teases 'promising' phase 2 data for closely watched KRAS prospect
Fierce Biotech
Amgen
clinical trials
non-small cell lung cancer
KRAS
sotorasib
Flag link:
HHS gives Vaxxas $22M to support vaccine patch tech
HHS gives Vaxxas $22M to support vaccine patch tech
Mass Device
Vaxxas
BARDA
HHS
clinical trials
vaccines
vaccine patches
devices
Flag link:
Pfizer and BioNTech Have Enrolled 83% of Their Up-Sized Coronavirus Vaccine Trial
Pfizer and BioNTech Have Enrolled 83% of Their Up-Sized Coronavirus Vaccine Trial
Motley Fool
Pfizer
BioNTech
clinical trials
BNT162b2
vaccines
COVID-19
Flag link:
Clinical Trial Software Company Hit by Massive Ransomware Attack
Clinical Trial Software Company Hit by Massive Ransomware Attack
BioSpace
clinical trials
Universal Health Services
ransomware
cyberhacking
cyberattacks
Flag link:
Report: Moderna and Pfizer Vaccine Trial Participants Report Serious Side Effects
Report: Moderna and Pfizer Vaccine Trial Participants Report Serious Side Effects
Motley Fool
clinical trials
Moderna Therapeutics
Pfizer
side effects
vaccines
COVID-19
Flag link:
Bristol Myers’ Hirawat on Pipeline Progress, Clinical Trial Diversity
Bristol Myers’ Hirawat on Pipeline Progress, Clinical Trial Diversity
Xconomy
Bristol-Myers Squibb
Celgene
clinical trials
clinical trial diversity
Samit Hirawat
Flag link:

Pages